Francisco J. Ramos-Lima

发表

Synthesis, characterization and tumor cell growth inhibition of new trans platinum complexes with phosphane derivatives

A. Bergamo, G. Sava, A. Quiroga, 2011 .

The role of p53 in the cellular toxicity by active trans-platinum complexes containing isopropylamine and hydroxymethylpyridine.

A. Carnero, V. Moneo, A. Quiroga, 2010, European journal of medicinal chemistry.

Rapid identification of ETP-46992, orally bioavailable PI3K inhibitor, selective versus mTOR.

M. Barbacid, F. Mulero, P. Pizcueta, 2012, Bioorganic & medicinal chemistry letters.

Identification of ETP-46321, a Potent and Orally Bioavailable PI3K α, δ Inhibitor.

M. Barbacid, F. Mulero, P. Pizcueta, 2012 .

Preparation, characterization and cytotoxic activity of new compounds trans-[PtCl2NH3(3-(hydroxymethyl)-pyridine)] and trans-[PtCl2NH3(4-(hydroxymethyl)-pyridine)]

A. Quiroga, Francisco J. Ramos-Lima, J. Pérez, 2003 .

Synthesis and Characterization of New Transplatinum Complexes Containing Phosphane Groups − Cytotoxic Studies in Cisplatin-Resistant Cells

X. Solans, A. Quiroga, M. Font‐Bardia, 2003 .

New trans-platinum drugs with phosphines and amines as carrier ligands induce apoptosis in tumor cells resistant to cisplatin.

A. Carnero, A. Quiroga, F. Blanco, 2007, Journal of medicinal chemistry.

Influence of (Hydroxymethyl)pyridine and Pyridine‐carboxylic Acids, in trans‐Position to the Isopropylamine and Ammine Ligands, on the Cytotoxicity of Platinum Complexes

A. Carnero, V. Moneo, A. Quiroga, 2008, Chemistry & biodiversity.

Identification of novel PI3K inhibitors through a scaffold hopping strategy.

J. Bischoff, C. Blanco-Aparicio, R. Álvarez, 2017, Bioorganic & medicinal chemistry letters.

Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial

I. González-Álvaro, F. Abad‐Santos, R. García-Vicuña, 2020, Trials.

Structural characterization, DNA interactions, and cytotoxicity of new transplatin analogues containing one aliphatic and one planar heterocyclic amine ligand.

V. Brabec, A. Quiroga, Francisco J. Ramos-Lima, 2006, Journal of medicinal chemistry.

Identification of ETP-46321, a potent and orally bioavailable PI3K α, δ inhibitor.

M. Barbacid, F. Mulero, P. Pizcueta, 2012, Bioorganic & medicinal chemistry letters.